Ignite Creation Date:
2024-05-05 @ 4:47 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00310375
Status:
COMPLETED
Last Update Posted:
2020-07-31
First Post:
2006-03-30
Brief Title:
Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial
Sponsor:
Organization:
GlaxoSmithKline